Knowledge (XXG)

Template:Antigout preparations

Source 📝

37: 291: 251: 30: 334: 413: 308: 145: 296: 222: 338: 154: 302: 90: 80: 407: 348: 267: 85: 208: 111: 51: 276: 271: 197: 162: 121: 116: 246: 230: 188: 172: 167: 106: 75: 60: 262: 126: 15: 202: 193: 131: 376:
will show the template collapsed, i.e. hidden apart from its title bar.
341:), it is hidden apart from its title bar; if not, it is fully visible. 257: 333:, meaning that if there is another collapsible item on the page (a 47: 19: 400:
will show the template expanded, i.e. fully visible.
379: 355: 239: 221: 181: 153: 144: 99: 68: 59: 344:To change this template's initial visibility, the 31: 8: 150: 65: 38: 24: 16: 328:initial visibility currently defaults to 345: 7: 339:table with the collapsible attribute 14: 1: 146:Xanthine oxidase inhibitors 430: 286: 414:Drug templates by ATC 384:Antigout preparations 360:Antigout preparations 313:Never to phase III 223:Mitotic inhibitors 323: 322: 217: 216: 140: 139: 421: 399: 398: 394: 391: 388: 385: 382: 375: 374: 370: 367: 364: 361: 358: 347: 346:|state= 331: 326:This template's 155:purine analogues 151: 66: 40: 33: 26: 17: 429: 428: 424: 423: 422: 420: 419: 418: 404: 403: 396: 392: 389: 386: 383: 380: 372: 368: 365: 362: 359: 356: 335:navbox, sidebar 329: 324: 319: 318: 303:Clinical trials 282: 235: 213: 177: 136: 95: 55: 46:Drugs used for 44: 12: 11: 5: 427: 425: 417: 416: 406: 405: 402: 401: 377: 321: 320: 317: 316: 315: 314: 311: 300: 294: 288: 287: 284: 283: 281: 280: 274: 265: 260: 249: 243: 241: 237: 236: 234: 233: 227: 225: 219: 218: 215: 214: 212: 211: 206: 200: 191: 185: 183: 179: 178: 176: 175: 170: 165: 159: 157: 148: 142: 141: 138: 137: 135: 134: 129: 124: 119: 114: 109: 103: 101: 97: 96: 94: 93: 91:Isobromindione 88: 83: 81:Sulfinpyrazone 78: 72: 70: 63: 57: 56: 45: 43: 42: 35: 28: 20: 13: 10: 9: 6: 4: 3: 2: 426: 415: 412: 411: 409: 378: 354: 353: 352: 351:may be used: 350: 342: 340: 336: 332: 312: 310: 307: 306: 304: 301: 298: 295: 293: 290: 289: 285: 278: 275: 273: 269: 268:Urate oxidase 266: 264: 261: 259: 256: 253: 250: 248: 245: 244: 242: 238: 232: 229: 228: 226: 224: 220: 210: 207: 204: 201: 199: 195: 192: 190: 187: 186: 184: 180: 174: 171: 169: 166: 164: 161: 160: 158: 156: 152: 149: 147: 143: 133: 130: 128: 125: 123: 120: 118: 115: 113: 110: 108: 105: 104: 102: 98: 92: 89: 87: 86:Benzbromarone 84: 82: 79: 77: 74: 73: 71: 67: 64: 62: 58: 53: 49: 41: 36: 34: 29: 27: 22: 21: 18: 343: 330:autocollapse 327: 325: 254: 209:Topiroxostat 203:Myo-inositol 112:Atorvastatin 23: 299:from market 277:Pegloticase 272:Rasburicase 198:Phytic acid 163:Allopurinol 122:Guaifenesin 117:Fenofibrate 61:Uricosurics 247:Cinchophen 231:Colchicine 189:Febuxostat 173:Tisopurine 168:Oxypurinol 107:Amlodipine 76:Probenecid 371:collapsed 349:parameter 309:Phase III 297:Withdrawn 263:Sevelamer 194:Inositols 127:Lesinurad 100:secondary 408:Category 395:expanded 132:Losartan 258:aspirin 69:primary 292:WHO-EM 255:except 252:NSAIDs 390:state 366:state 337:, or 240:Other 182:other 48:gout 52:M04 410:: 397:}} 381:{{ 373:}} 357:{{ 305:: 393:= 387:| 369:= 363:| 279:) 270:( 205:) 196:( 54:) 50:( 39:e 32:t 25:v

Index

v
t
e
gout
M04
Uricosurics
Probenecid
Sulfinpyrazone
Benzbromarone
Isobromindione
Amlodipine
Atorvastatin
Fenofibrate
Guaifenesin
Lesinurad
Losartan
Xanthine oxidase inhibitors
purine analogues
Allopurinol
Oxypurinol
Tisopurine
Febuxostat
Inositols
Phytic acid
Myo-inositol
Topiroxostat
Mitotic inhibitors
Colchicine
Cinchophen
NSAIDs

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.